| 标题 |
Clinical efficacy and safety of immune checkpoint inhibitors plus anlotinib as secondline or subsequent therapy in extensive stage small cell lung cancer: a retrospective study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 作者:Wu Y; Zhang Y; Tian Y; Lv Y; Zhang J 出版日期:2025/03/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)